Management of Drowsiness in CKD Hemodialysis Patients

Systematic Assessment

The National Kidney Foundation recommends using validated screening tools, such as the Edmonton Symptom Assessment System-revised: Renal (ESAS-r:Renal), to quantify drowsiness severity and identify concurrent symptoms at each dialysis visit 2, 1
The American Academy of Sleep Medicine suggests assessing sleep quality using the Pittsburgh Sleep Quality Index (PSQI), as scores ≥5 indicate poor sleep quality affecting 65-83% of dialysis patients and contributing significantly to daytime drowsiness 1
The Kidney Disease: Improving Global Outcomes (KDIGO) guidelines recommend evaluating for intradialytic hypotension (IDH), which causes post-dialysis fatigue and drowsiness through hemodynamic instability and inadequate cerebral perfusion 3
The American Psychiatric Association recommends screening for depression, which has a prevalence of 39.3% in dialysis patients using self-rating scales and is strongly associated with drowsiness and reduced quality of life 2

The American College of Cardiology recommends increasing dialysis frequency to at least three times weekly as the foundation of management, since twice-weekly dialysis is only appropriate for patients with substantial residual kidney function 1
The European Renal Association - European Dialysis and Transplant Association (ERA-EDTA) suggests considering extended or more frequent hemodialysis (4-6 times weekly) to further improve uremic symptoms and quality of life, though evidence certainty is low 1
The International Society of Nephrology recommends achieving and maintaining target dry weight through adequate ultrafiltration, as volume overload contributes to cardiovascular symptoms and overall symptom burden 1
The American Society of Nephrology recommends considering alternative modalities such as isolated ultrafiltration, hemofiltration, or hemodiafiltration for resistant cases, which provide improved hemodynamic stability compared to conventional HD 3

The American Academy of Neurology recommends gabapentin 100-300 mg after each dialysis session as the preferred first-line pharmacologic agent for neurologic and sleep-related symptoms in dialysis patients, with proven efficacy and favorable safety profile 1, 4
The American Geriatrics Society recommends avoiding benzodiazepines, which may worsen cognitive function in patients already at risk for uremic encephalopathy 4
The National Institute of Mental Health suggests not using sedating antihistamines long-term due to limited efficacy and increased dementia risk 4
The American Psychiatric Association recommends considering selective serotonin reuptake inhibitors for concurrent depression, though evidence in dialysis patients is mixed 2

The American Heart Association recommends administering cardiovascular medications at night to avoid intradialytic hypotension, which causes post-dialysis fatigue and drowsiness 1
The European Society of Cardiology suggests considering combination modalities such as midodrine with dialysate temperature profiling, or dialysate temperature profiling with 3 mEq/L dialysate calcium for patients with IDH 3
The International Society of Nephrology recommends intravenous L-carnitine therapy at 20 mg/kg into the dialysis venous port with each session, which may reduce IDH frequency and thereby reduce post-dialysis fatigue 3

The American Psychological Association recommends cognitive behavioral therapy (CBT), which has proven efficacy in reducing depression and may improve sleep quality, thereby reducing daytime drowsiness 1

The National Kidney Foundation recommends reassessing drowsiness severity at each dialysis visit using standardized tools to track treatment response 1
The American Geriatrics Society suggests evaluating medication efficacy and adverse effects, especially cognitive changes and falls, as patients with CKD are at high risk for medication-related problems due to complex regimens 1
The American Academy of Neurology recommends monitoring for progression of neurologic symptoms despite treatment and assessing for other uremic symptoms that commonly coexist, including restless legs syndrome, sleep disorders, and depression 4

The American College of Emergency Physicians recommends escalating care urgently if drowsiness is accompanied by altered mental status or confusion, seizure activity, severe electrolyte abnormalities, volume overload refractory to current dialysis prescription, or progressive nutritional deterioration 4, 1

The National Kidney Foundation recommends not attributing drowsiness solely to "uremia" without systematically assessing and addressing modifiable factors such as dialysis adequacy, volume status, medication timing, and concurrent depression 2, 1